Navigation Links
Monogram Announces 2008 Second Quarter Financial Results
Date:7/29/2008

for results prepared in accordance with GAAP. Above, management has provided a reconciliation of the Non-GAAP proforma financial information with the comparable financial information reported in accordance with GAAP.

MONOGRAM BIOSCIENCES, INC.

SELECTED BALANCE SHEET DATA

(In thousands)

(Unaudited)

June 30, December 31,

2008 2007(1)

ASSETS

Current assets:

Cash and cash equivalents $21,943 $18,762

Short-term investments 4,984 11,828

Accounts receivable, net 13,731 9,100

Prepaid expenses 1,164 1,279

Inventory 1,761 1,250

Other current assets 1,249 917

Total current assets 44,832 43,136

Property and equipment, net 7,913 7,665

Goodwill 9,927 9,927

Deferred costs 12,675 8,043

Other assets 94 540

Total assets $75,441 $69,311

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:

Accounts payable $1,765 $2,116

Accrued compensation 5,402 3,324

Accrued liabilities 4,708 3,818

Current portion of restructuring

costs 610 610

Deferred revenue, current portion 727 605

C
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Monogram Announces First Medicare Payment for Trofile(TM)
2. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
3. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
4. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
5. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 1New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 2New HHS HRSA Grant Will Fund Development of an Electronic Genetic and Family History Record for Doctors Offices 51651 3Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 1Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 2Pederson Immigration Law Group Attorneys Featured in 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51648 3meridianEMR Completes Surescripts 28R 29 Certification 51645 1meridianEMR Completes Surescripts 28R 29 Certification 51645 2meridianEMR Completes Surescripts 28R 29 Certification 51645 3